Adrenal Cortex Diseases: Clinical Trials

9 trials for Adrenal Cortex Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 unknown. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 8, Unknown 1

Follow Adrenal Cortex Diseases: new trials by email Literature Review of Adrenal Cortex Diseases trials Research Report on Adrenal Cortex Diseases

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
Cisplatin plus Etoposide, Observation or Mitotane - Adrenocortical Carcinoma
Phase 3CompletedAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia402018-07-202024-08-01
SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan.
Ct-scan or adrenal vein sampling - Hyperaldosteronism
Phase 3CompletedRadboud University Medical Center2002010-07-012015-07-16
A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
OSI-906, Placebo - Adrenocortical Carcinoma
Phase 3CompletedAstellas Pharma Inc1392009-12-012024-11-20
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
mifepristone - Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics302009-07-012014-04-02
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
MITOTANE - Adrenocortical Carcinoma
Phase 3UnknownUniversity of Turin, Italy2002008-04-012017-05-08
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
mifepristone - Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics502007-12-012013-08-22
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Cisplatin, Conventional Surgery, Doxorubicin Hydrochloride - Stage I Adrenal Cortical Carcinoma AJCC v7, Stage II Adrenal Cortical Carcinoma AJCC v7
Phase 3CompletedChildren's Oncology Group782007-05-032024-02-28
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Etoposide, Doxorubicin, Cisplatin - Carcinoma, Adrenal Cortical
Phase 3CompletedCollaborative Group for Adrenocortical Carcinoma Treatment3042004-06-012016-09-21

Narrower conditions

Adrenocortical Carcinoma (6)  ·  ACTH Syndrome, Ectopic (2)  ·  Adrenal Cortex Neoplasms (2)  ·  Choristoma (2)  ·  Cushing Syndrome (2)  ·  Hirsutism (2)  ·  Pituitary ACTH Hypersecretion (2)  ·  Pituitary Diseases (2)  ·  Adrenocortical Adenoma (1)  ·  Anus Neoplasms (1)  ·  Appendiceal Neoplasms (1)  ·  Astrocytoma (1)  ·  Bile Duct Neoplasms (1)  ·  Blast Crisis (1)  ·  Brain Neoplasms (1)

Broader conditions

Adrenal Gland Diseases (9)  ·  Adrenal Gland Neoplasms (9)  ·  Endocrine Gland Neoplasms (9)  ·  Endocrine System Diseases (9)  ·  Neoplasms by Site (9)  ·  Neoplasms (8)  ·  Adrenal Cortex Neoplasms (7)  ·  Adenocarcinoma (6)  ·  Carcinoma (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Adrenocortical Hyperfunction (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)

Interventions

Mitotane (4)  ·  Cisplatin (3)  ·  Etoposide (3)  ·  Corlux (2)  ·  Doxorubicin (2)  ·  Mifepristone (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (1)  ·  Chemotherapy, Adjuvant (1)  ·  Dichlorodiphenyldichloroethane (1)  ·  Ethane (1)  ·  Fentanyl (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Observation (1)

Sponsors

Corcept Therapeutics (2)  ·  Astellas Pharma Inc (1)  ·  Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Children's Oncology Group (1)  ·  Collaborative Group for Adrenocortical Carcinoma Treatment (1)  ·  INSYS Therapeutics Inc (1)  ·  Radboud University Medical Center (1)  ·  University of Turin, Italy (1)

Countries

United States (7)  ·  Italy (4)  ·  Netherlands (4)  ·  Australia (3)  ·  Canada (3)  ·  France (3)  ·  Germany (3)  ·  United Kingdom (2)  ·  Austria (1)  ·  Brazil (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Alfredo Berruti, MD (2)  ·  Martin Fassnacht, MD (2)  ·  Britt Skogseid, MD (1)  ·  Carlos Rodriguez-Galindo (1)  ·  Coleman Gross (1)  ·  Coleman Gross, MD (1)  ·  Eric Baudin, MD (1)  ·  Harm Haak, MD (1)  ·  Jacob Deinum, Dr. (1)  ·  Larry Dillaha, MD (1)  ·  Massimo Terzolo, MD (1)

Results publications

PMID 22551107, PMID 25013998, PMID 26507877, PMID 11762335, PMID 15867769, PMID 16680602, PMID 17554118, PMID 18506026, PMID 19494162, PMID 19851811, PMID 20580485, PMID 21470991, PMID 22466348, PMID 22480131, PMID 22997446, PMID 23150683, PMID 23704714, PMID 23970019, PMID 23970725, PMID 25559399, PMID 25795408, PMID 27020837, PMID 27325147, PMID 29099925, PMID 34675114, PMID 37619579, PMID 9716042, PMID 9827725

NIH funding

2009 (1), U10CA098543 (1), U10CA180886 (1)